Note- old diseases and conditions continue to return, such

New Post Public Reply Private Reply Replies (2) Message Board
microcaps microcaps #5594
498
Note- old diseases and conditions continue to return, such as tb, measles etc. The bubonic plague itself continues to affect Americans. e.g.,https://www.scientificamerican.com/article/100-years-of-bubonic-plague/
Plus a panoply of new diseases/conditions will continue to grow as per many sources-so whether or not NNLX's N-assay is used for the current pandemic, the N -assay will continue to be useful against a wide range of bacterial and viral conditions in the future,as NNLX has noted, especially in comparison to the more limited diagnosis afforded by the current pcr or pcp tech.

And yes, the govt contractor -whoever they are -who showed an interest in NNLX's N- assay -as per a preliminary agreement- is not likely to disappear in a week or two. I've explained ad nauseum in the past why it takes so long for things to move forward,given the required dd and communication among several disparate specialized groups who do not speak the same language.


almost all drugs have side effects and become toxic at some level of dosage. E.g., I've read that acetaminophen can cause liver failure at just 4000 mg/day (in fact in some cases as low as 2000mg/day i think i've read)=-bottles say do not exceed 4000mg/day or use with certain other drugs or take 3 or more alcoholic drinks/day. Untreated liver failure results in death.

https://www.uspharmacist.com/article/acetamin...ed-to-know

from the cited article: Acetaminophen toxicity is one of the most common causes of both intentional and unintentional poisoning in the U.S. In fact, there has been a steady increase in the incidence of acetaminophen-related toxicity over the past decade.... Acetaminophen-associated overdoses account for approximately 56,000 emergency department visits, 26,000 hospitalizations, and over 450 deaths annually.9

if such a commonly used drug as acetaminophen is so toxic then its odd that a reported side effect in just ONE wrong self diagnosed self treating patient was used in one article https://fortune.com/2020/03/20/malaria-drug-c...dly-china/ to caution against chloroquine treatment for covid 19- such a strange event/article title is more likely part of current widespread political assassination attempts.

the ff was the journal article cited by my post
https://www.sciencedirect.com/science/article...via%3Dihub

https://www.ncbi.nlm.nih.gov/pubmed/32164085
the wiki article https://en.wikipedia.org/wiki/Chloroquine notes that
a further study concluded that hydroxychloroquine was more potent than chloroquine, with a more tolerable safety profile

one article said the older less safe form of chloroquine was widely used by europeans before entering any malaria prone theater and that said europeans continued on a dosage of such for 2 months AFTER exiting malaria prone areas. Obviously- even the older less safe form of the treatment were considered an improvement compared to malaria.

Of course, today safety is emphasized more than decades ago,but in all cases drugs are intended for particular uses under a doctors direction- and are not to be used willy nilly as per a wrong self diagnosis as did the chinese woman who developed arrhythmia- which is contraindicated for chloroquine, just as a long list of drugs are contraindicated for those with heart problems. In most such cases it is the side effect which kills -often in people prone to such a side effect.
In italy i've read that up to 99% of deaths occurred in those with a previous underlying medical condition.
As French and Australian and Chinese work with chloroquine (which was also effective against some previous corona viruses) and its safer derivatives came to light it was naturally jumped on as a possible treatment modality, and it still is, since regulatory approval for all potential vaccines seems to be one year away, according to reports i've read and heard.

So non-scientists, including politicians, will in the current climate of runaway fear be glad to push such a potential treatment.
That is part of their job to calm fears in a fear prone populace.

Meanwhile scientists,who by nature must be more cautious -want to look at the studies first and determine whether other studies or tests are necessary for safety purposes before jumping into the boat. This paradigm should be well known and understood-and remember it was scientists use of chloroquine or its safer derivatives and their scientific statements that such use was highly effective against the virus in their studies/samples that got politicians and others excited,as it should-why -because we cannot idly sit by and wait one year for a vaccine to be approved before we start to combat the virus. That should be obvious.



Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 0

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 1

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 1

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 3

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 8

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

Toll Brothers Unveils Stunning New Homes in Chapel Oaks

Updated Category News Views 200

Exciting New Model Homes at Chapel Oaks Community CHAPEL HILL, N.C. – Toll Brothers, Inc. (NYSE: TOL), a prominent name in luxury home construction, has recently announced the opening of their latest model home at the Chapel Oaks community. This new community marks a significant addition to their portfolio in the Raleigh area, providing prospective homeowners with...

Continue Reading
Harbour BioMed Projects Significant Profit Growth for 2025

Updated Category News Views 117

Positive Profit Alert for Harbour BioMed Harbour BioMed, a prominent global biopharmaceutical company, recently announced optimistic profit projections for the year ending December 31, 2025. This announcement comes as a part of their continuous commitment to pioneering antibody therapeutics within the fields of immunology and oncology. Financial Expectations and Growth...

Continue Reading
Watsco Prepares for Significant Q2 Earnings Call This Summer

Updated Category News Views 112

Watsco's Upcoming Second Quarter Earnings Call Watsco, Inc. (NYSE: WSO), a leader in the distribution of heating, air conditioning, and refrigeration (HVAC/R) products, is all set to host its anticipated second quarter earnings call. This event will take place soon, promising insights into the company’s performance and future projections. Investors and analysts alike...

Continue Reading
Innovative AI Technology by Garrett Metal Detectors Transformed

Updated Category News Views 140

Groundbreaking Insights into AI Innovations in Security Detection Located in Texas, Garrett Metal Detectors has introduced a revolutionary product in the field of security technology. The company recently unveiled their latest innovation: the Paragon walk-through metal detector, which is now powered by Clarity, an advanced AI-driven development platform. This platform...

Continue Reading
ProVen VCT plc Announces Significant Director Share Purchases

Updated Category News Views 121

ProVen VCT plc: Recent Director Shareholding Activity ProVen VCT plc has made headlines with recent transactions involving its directors. The company disclosed that several of its directors have bought ordinary shares of 10 pence each recently. This activity reflects confidence in the company's performance and future prospects. Details of Director Transactions James...

Continue Reading